PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-60.36%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-55.68%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-110.17%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-112.99%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-120.93%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-120.93%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-120.93%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-73.53%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
125.84%
Positive 5Y CAGR while 6617.T is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
89.60%
Positive 3Y CAGR while 6617.T is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
100.00%
OCF/share CAGR of 100.00% while 6617.T is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
93.45%
Positive 10Y CAGR while 6617.T is negative. John Neff might see a substantial advantage in bottom-line trajectory.
-10.61%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
25.19%
Positive short-term CAGR while 6617.T is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
57.75%
5Y equity/share CAGR above 1.5x 6617.T's 3.60%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
42.85%
3Y equity/share CAGR above 1.5x 6617.T's 1.85%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-8.41%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
18.22%
Inventory growth well above 6617.T's 12.41%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.43%
Positive asset growth while 6617.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-1.62%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
24.55%
We have some new debt while 6617.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-25.50%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-5.10%
We cut SG&A while 6617.T invests at 191.92%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.